Compare Foundation Medicine vs iMMCO Diagnostics
Customers evaluate the quality of Foundation Medicine's products using the following success metrics.
Overview
Foundation Medicine is 14 yrs old and is based in United States.
Foundation Medicine offers cancer care treatments. It develops an informative genomic profile to identify a patient's individual molecular alterations and match them with relevant targeted therapies and clinical trials. It was founded in 2010 and is based in Cambridge, Massachusetts. In June 2018, Foundation Medicine was acquired by Roche Holdings.
iMMCO Diagnostics is based in United States
IMMCO Diagnostics provides high-quality diagnostic test kits and lab testing services worldwide for the screening of autoimmune disorders. IMMCO Diagnostics incorporates working on research, clinical laboratory expertise, and medical devices into an approach to autoimmune diagnostics.
Demo Video
Leadership
Ronald Collette (Chief Information Officer)
William J. Maggio (Owner)
Funding
Investors
Roche, Yuri Milner
Paycheck Protection Program and Summit Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Foundation Medicine has not claimed their profile.
Work for Foundation Medicine? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Foundation Medicine?
Claim your profile now.
Information not available because iMMCO Diagnostics has not claimed their profile.
Work for iMMCO Diagnostics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for iMMCO Diagnostics?
Claim your profile now.
News & Analysis
Foundation Medicine has been mentioned in our research 2 times.
iMMCO Diagnostics has not been mentioned in our research.
Research Articles
Expert Collections
Drug Discovery Tech Market Map
221 items
This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.